VMP 42213311000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Methyldopa 250mg tablets
BNF code 0205020H0AAADAD
Virtual Therapeutic Moiety Methyldopa
Date identifier became valid 1 Sep 2023
Previous product identifier 318672001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Methyldopa (anhydrous)
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Aldomet 250mg tablets (Sigma Pharmaceuticals Plc)
Methyldopa 250mg tablets (A A H Pharmaceuticals Ltd)
Methyldopa 250mg tablets (Accord-UK Ltd)
Methyldopa 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Methyldopa 250mg tablets (Aspen Pharma Trading Ltd)
Methyldopa 250mg tablets (Bristol Laboratories Ltd)
Methyldopa 250mg tablets (Ennogen Pharma Ltd)
Methyldopa 250mg tablets (Flamingo Pharma (UK) Ltd)
Methyldopa 250mg tablets (Medihealth (Northern) Ltd)
Methyldopa 250mg tablets (Phoenix Healthcare Distribution Ltd)
Methyldopa 250mg tablets (Sigma Pharmaceuticals Plc)
Methyldopa 250mg tablets (Sigma Pharmaceuticals Plc)
Methyldopa 250mg tablets (Sovereign Medical Ltd)
Virtual Medicinal Product Packs
Methyldopa 250mg tablets 1000 tablet
Methyldopa 250mg tablets 500 tablet
Methyldopa 250mg tablets 56 tablet
Methyldopa 250mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.

Feedback